Clinical trials: Chronic Schizophrenia
Schizophrenia, Schizoaffective Disorder
Safety and Tolerability of BL-1020 in Hospitalized Subjects With Chronic Schizophrenia or Schizo-Affective Disorder
An open-label, multi-center, 6-week, sequential cohort study designed to determine the safety and tolerability of two dose ranges of BL-1020 in hospitalized subjects with chronic schizophrenia or schizo-affective disorder
- Trial name
- NCT00480571
- Testing
- BL-1020, BL 1020 High Dose
- Where
- 2 sites in Israel, Romania
- Volunteers
- 90 people
- Sponsor
- BioLineRx, Ltd.
Schizophrenia, Obsessive Compulsive Disorder
Chronic Schizophrenia With Obsessive-Compulsive Symptoms: Comorbidity or a Subtype?
Evaluating the prevalence and characteristics of obsessive-compulsive (OC) symptoms in patients with chronic schizophrenia
- Trial name
- NCT00269464
- Sponsor
- Sheba Medical Center
Schizophrenia
Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder
This is an open label 8-week trial of modafinil up to 400 mg daily added to a stable antipsychotic regimen to evaluate the effect modafinil on cognition, sedation, and weight in patients with chronic schizophrenia.
- Trial name
- NCT00838227
- Testing
- modafinil
- Sponsor
- Manhattan Psychiatric Center
Schizophrenia, Auditory Verbal Hallucinations
Neuronavigated rTMS for Treatment-Resistant Auditory Hallucinations
Auditory verbal hallucinations (AVH), such as hearing voices in the absence of an external sound source, are a common and distressing symptom of schizophrenia.
- Trial name
- fuNEEG (NCT07856368)
- Testing
- Neuronavigated repetitive transcranial magnetic stimulation (rTMS)
- Where
- Switzerland
- Volunteers
- 40 people
- Sponsor
- Psychiatric University Hospital, Zurich